MyFinsight
Home
Blog
About
Proceeds from public
offering
$5,085,000
(178.08%↑ Y/Y)
Exercise of warrants
$2,719,185
(23.86%↑ Y/Y)
Net cash provided by
financing activities
$7,804,185
(97.66%↑ Y/Y)
Net increase
(decrease) in cash and cash...
$6,881,088
(2246.06%↑ Y/Y)
Canceled cashflow
$923,097
Inventory
-$793,996
(-170.65%↓ Y/Y)
Prepaid expenses
-$133,703
(47.68%↑ Y/Y)
Stock issued for
services
$96,900
Depreciation and
amortization
$77,974
(-43.22%↓ Y/Y)
Reduction in right-of-use
asset
$49,977
(152.94%↑ Y/Y)
Purchase of intangible
assets
-$1,895
(-100.32%↓ Y/Y)
Net cash (used in)
operating activities
-$917,977
(69.27%↑ Y/Y)
Net cash (used in)
investing activities
-$5,120
(99.23%↑ Y/Y)
Canceled cashflow
$1,152,550
Canceled cashflow
$1,895
Net (loss)
-$1,564,048
(46.99%↑ Y/Y)
Purchase of equipment
$7,015
(-95.81%↓ Y/Y)
Deposits
$209,740
Accounts payable &
accrued expenses
-$156,687
(81.56%↑ Y/Y)
Accounts receivable
$88,610
(118.00%↑ Y/Y)
Lease liability
-$51,267
(-167.87%↓ Y/Y)
Income tax payable
-$175
(98.27%↑ Y/Y)
Back
Back
Cash Flow
Sunshine Biopharma Inc. (SBFM)
Sunshine Biopharma Inc. (SBFM)
source: myfinsight.com